PMID- 7769266 OWN - NLM STAT- MEDLINE DCOM- 19950706 LR - 20190723 IS - 0022-202X (Print) IS - 0022-202X (Linking) VI - 104 IP - 6 DP - 1995 Jun TI - Comparative study of hepatocyte growth factor/scatter factor and keratinocyte growth factor effects on human keratinocytes. PG - 958-63 AB - Hepatocyte growth factor/scatter factor (HGF/SF) and keratinocyte growth factor (KGF, also designated FGF-7) are paracrine growth factors secreted by mesenchymal cells and active on a variety of epithelial cell types. In this study, the biologic responses of keratinocytes to these paracrine growth factors were compared. Stimulation of mitogenesis, migration, plasminogen activator (PA) activity, and fibronectin production were examined using human foreskin keratinocytes cultured in serum-free MCDB 153 medium. Although the two factors stimulated a similar level of proliferation when cells were maintained for 5 d in 1.8 mM Ca++, the peak effect of KGF, observed at 10 ng/ml, was approximately threefold higher than that of HGF/SF when cells were in medium containing 0.15 mM Ca++. Both agents promoted the migration of cells in low-calcium medium (0.08 mM Ca++). However, the magnitude of the response was approximately twofold greater for HGF/SF at 10 ng/ml than KGF at the same concentration. None of the matrix proteins such as type I collagen, type IV collagen, laminin, or fibronectin either stimulated or suppressed HGF/SF- or KGF-stimulated keratinocyte migration. Both factors stimulated PA activity of the cell extracts, especially urokinase-type, with similar potencies. Promoted PA activity was maximal with the addition of 10 ng/ml of either factor. Neither factor increased the production of fibronectin under conditions in which transforming growth factor-beta 1 was active. These results indicate that HGF/SF and KGF, both recognized as paracrine growth factors, elicit distinctive patterns of response by keratinocytes, implying that they have different roles in epidermal physiology. FAU - Sato, C AU - Sato C AD - Department of Dermatology, Juntendo University School of Medicine, Tokyo, Japan. FAU - Tsuboi, R AU - Tsuboi R FAU - Shi, C M AU - Shi CM FAU - Rubin, J S AU - Rubin JS FAU - Ogawa, H AU - Ogawa H LA - eng PT - Comparative Study PT - Journal Article PL - United States TA - J Invest Dermatol JT - The Journal of investigative dermatology JID - 0426720 RN - 0 (FGF7 protein, human) RN - 0 (Fibroblast Growth Factor 10) RN - 0 (Fibronectins) RN - 0 (Growth Substances) RN - 126469-10-1 (Fibroblast Growth Factor 7) RN - 62031-54-3 (Fibroblast Growth Factors) RN - 67256-21-7 (Hepatocyte Growth Factor) RN - EC 3.4.21.- (Plasminogen Activators) SB - IM MH - Cell Movement/drug effects MH - Fibroblast Growth Factor 10 MH - Fibroblast Growth Factor 7 MH - *Fibroblast Growth Factors MH - Fibronectins/biosynthesis MH - Growth Substances/*pharmacology MH - Hepatocyte Growth Factor/*pharmacology MH - Humans MH - Keratinocytes/cytology/*drug effects/physiology MH - Plasminogen Activators/pharmacology EDAT- 1995/06/01 00:00 MHDA- 1995/06/01 00:01 CRDT- 1995/06/01 00:00 PHST- 1995/06/01 00:00 [pubmed] PHST- 1995/06/01 00:01 [medline] PHST- 1995/06/01 00:00 [entrez] AID - S0022-202X(15)42203-1 [pii] AID - 10.1111/1523-1747.ep12606221 [doi] PST - ppublish SO - J Invest Dermatol. 1995 Jun;104(6):958-63. doi: 10.1111/1523-1747.ep12606221.